Article
Insights into the mechanism of dihydropyrimidine dehydrogenase from site-directed mutagenesis targeting the active site loop and redox cofactor coordination.
Biochimica et biophysica acta - 1 Dec 2010
Lohkamp Bernhard, Voevodskaya Nina, Lindqvist Ylva, Dobritzsch Doreen
Abstract excerpt
In mammals, the pyrimidines uracil and thymine are metabolised by a three-step reductive degradation pathway. Dihydropyrimidine dehydrogenase (DPD) catalyses its first and rate-limiting step, reducing uracil and thymine to the corresponding 5,6-dihydropyrimidines in an NADPH-dependent reaction. The enzyme is an adjunct target in cancer therapy since it rapidly breaks down the anti-cancer drug 5-fluorouracil and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
